gip/glp-1 receptor agonist drugs list of glp-1 for weight loss GLP-1 medications mentioned by the WHO. The GLP-1 receptor agonists and beyond.

Garg continued

While prior large-scale studies earlier in 2024 did not find an association between GLP-1 receptor agonists and retinopathy, this recent case series suggests that a subset of patients may be vulnerable to optic nerve damage and other vision complications [1,2]

Borner T, Geisler CE, Fortin SM, et al

[DOI] [PubMed] [Google Scholar] 382.Chen J., Zhao H., Ma X., Zhang Y., Lu S., Wang Y

However, under a proposal from the Trump administration, Medicare coverage could begin for certain patients as early as this summer, with copayments potentially as low as $50 a month

In SUSTAIN 3, SUSTAIN 7 and SUSTAIN 10, the GLP-1RAs semaglutide reduced HbA1c by up to 1.8%, achieved the glycemic control target of HbA1c in 80% of the intervention group, and reduced BW by up to 6.5 kg, outcomes which were superior to liraglutide, exenatide and dulaglutide [28-30]